Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00042133.xml
Download PDF
CC BY-NC-ND 4.0 · Eur J Dent 2021; 15(04): 675-681
DOI: 10.1055/s-0041-1728230
DOI: 10.1055/s-0041-1728230
Original Article
A Meta-Analysis in Assessing Oxidative Stress Using Malondialdehyde in Oral Submucous Fibrosis
Funding None.
Abstract
Objective This study aimed to evaluate the oxidative stress (OS) marker Malondialdehyde (MDA) in oral submucous fibrosis with available literature.
Materials and Methods We conducted a literature search electronically in PubMed (MeSH), Science Direct, Scopus, and Google Scholar using specific keywords.
Results A systematic search in PubMed, Science Direct, and Google Scholar identified 334 articles. Of these, four were duplicate reports, and three were animal studies. After reading the abstracts of the collected articles, 288 articles were excluded for the following reasons: low quality, not relevant to the research question, or did not meet the inclusion criteria. The remaining 46 articles were chosen for full-text assessment. Finally, the present qualitative synthesis included 23 articles for evaluation. The selected studies in MDA analysis in a random-effects model showed higher heterogeneity (Q = 477.636, p < 0.001, I2 = 95.394%). The standard difference in mean MDA concentration between oral submucous fibrosis (OSMF) and healthy subjects was estimated as 2.73 nmol/mL (95% confidence interval: 2.08–3.38).
Conclusion The selected studies showed significantly higher MDA levels in various biological samples of patients with OSMF. Therefore, further studies are needed to estimate oxidative stress levels by using different biomarkers in OSMF to direct future therapy.
Publication History
Article published online:
24 August 2021
© 2021. European Journal of Dentistry. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Shetty SR, Babu SG, Kumari S, Rao V, Vijay R, Karikal A. Malondialdehyde levels in oral sub mucous fibrosis: a clinicopathological and biochemical study. N Am J Med Sci 2012; 4 (03) 125-128
- 2 Kanodia S, Giri VP, Giri OP, Devi MP, Garima Y. Assessment of anxiety, depression, and serum cortisol level in oral submucous fibrosis patients: a controlled clinical trial. Eur J Dent 2017; 11 (03) 293-298
- 3 Rajakumar P, Saravanan R, Prabhakar R, Kumar RV, Abinesh S, Vivakanandhan U. Role of anti-oxidants in oral submucous fibrosis. J Int Oral Health 2016; 8: 412-414
- 4 Poorani R, Vezhavendhan N, Ramesh R. Vidhya Lakshmi S, Sivaramakrishnan M, Suganya R. Malondialdehyde level in oral submucous fibrosis. J Sci Dent 2014; 4 (02) 8-13
- 5 D’souza D, Subhas BG, Shetty SR, Balan P. Estimation of serum malondialdehyde in potentially malignant disorders and post-antioxidant treated patients: a biochemical study. Contemp Clin Dent 2012; 3 (04) 448-451
- 6 Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 2006; 42 (06) 561-568
- 7 Vincent RR, Appukuttan D, Victor DJ, Balasundaram A. Oxidative stress in chronic periodontitis patients with type II diabetes mellitus. Eur J Dent 2018; 12 (02) 225-231
- 8 Canakci CF, Cicek Y, Yildirim A, Sezer U, Canakci V. Increased levels of 8-hydroxydeoxyguanosine and malondialdehyde and its relationship with antioxidant enzymes in saliva of periodontitis patients. Eur J Dent 2009; 3 (02) 100-106
- 9 Irshad M, Chaudhuri PS. Oxidant-antioxidant system: role and significance in human body. Indian J Exp Biol 2002; 40 (11) 1233-1239
- 10 Yegambaram M, Manivannan B, Beach TG, Halden RU. Role of environmental contaminants in the etiology of Alzheimer’s disease: a review. Curr Alzheimer Res 2015; 12 (02) 116-146
- 11 Anderson RA, Evans ML, Ellis GR. et al The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis 2001; 154 (02) 475-483
- 12 Sadaksharam J. Significance of serum nitric oxide and superoxide dismutase in oral submucous fibrosis and squamous cell carcinoma: a comparative study. Contemp Clin Dent 2018; 9 (02) 283-288
- 13 Matsui A, Ikeda T, Enomoto K. et al Increased formation of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett 2000; 151 (01) 87-95
- 14 Tseng SK, Chang MC, Su CY. et al Arecoline induced cell cycle arrest, apoptosis, and cytotoxicity to human endothelial cells. Clin Oral Investig 2012; 16 (04) 1267-1273
- 15 Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39 (01) 44-84
- 16 Lü JM, Lin PH, Yao Q, Chen C. Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J Cell Mol Med 2010; 14 (04) 840-860
- 17 Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J 2012; 5 (01) 9-19
- 18 Aradhya CBV, Britto F, Kaikure SLHG, Paul T, Sishan U, Abdulrashid B. Shubhalakshmi. “Oxidants to assess the oxidative stress in oral submucous fibrosis. Int J CurrAdv Res 2018; 7 (08) 14973-14975
- 19 Gokul S, Patil VS, Jailkhani R, Hallikeri K, Kattappagari KK. Oxidant-antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients. Oral Dis 2010; 16 (01) 29-33
- 20 Gupta S, Reddy MV, Harinath BC. Role of oxidative stress and antioxidants in aetiopathogenesis and management of oral submucous fibrosis. Indian J Clin Biochem 2004; 19 (01) 138-141
- 21 Agrawal S, Ambad RS. Evaluation of anti-oxidant status in oral submucous fibrosis: a hospital based study. Int J Innovat Res Med Sci 2017; 2: 7
- 22 Shakunthala GK, Annigeri RG, Arunkumar S. Role of oxidative stress in the pathogenesis of oral submucous fibrosis: A preliminary prospective study. Contemp Clin Dent 2015; 6 (Suppl. 01) S172-S174
- 23 Subramanyam D, Gurunathan D, Gaayathri R. Vishnu Priya V. Comparative evaluation of salivary malondialdehyde levels as a marker of lipid peroxidation in early childhood caries. Eur J Dent 2018; 12 (01) 67-70
- 24 Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol 2012; 2012: 137289
- 25 Slatter DA, Paul RG, Murray M, Bailey AJ. Reactions of lipid-derived malondialdehyde with collagen. J Biol Chem 1999; 274 (28) 19661-19669
- 26 Metkari S, Tupkari J, Barpande S. An estimation of serum malondialdehyde, superoxide dismutase and vitamin A in oral submucous fibrosis and its clinicopathologic correlation. J Oral Maxillofac Pathol 2007; 11 (01) 23-27
- 27 Uikey AK, Hazarey VK, Vaidhya SM. Estimation of serum anti-oxidant enzymes superoxide dismutase and glutathione peroxidase in oral submucous fibrosis: a biochemical study. J Maxillofac Pathol. 2003; 7: 44-52
- 28 Patel T, Kulkarni V. A study on anti-oxidant levels in non smoke tobacco consuming oral sub mucous fibrosis (OSMF). Int J Med Res Heal Sci 2013; 2: 229
- 29 Avinash Tejasvi ML, Bangi BB, Geetha P. et al Estimation of serum superoxide dismutase and serum malondialdehyde in oral submucous fibrosis: a clinical and biochemical study. J Cancer Res Ther 2014; 10 (03) 722-725
- 30 Purohit CS. Total anti-oxidant activity - a biomarker in oral precancer patients. Int J Curr Res Rev 2014; 6: 21-24
- 31 Rai S, Sharma A, Ranjan V, Misra D, Panjwani S. Estimation of serum anti-oxidant enzymes in histopathological grades of oral leukoplakia, oral submucous fibrosis, and oral cancer: a clinicopathologic study. J Indian Acad Oral Med Radiol 2015; 27: 349
- 32 Paulose S, Rangdhol V, Ramesh R, Jeelani SA, Brooklyin S. Estimation of serum malondialdehyde and assessment of DNA damage using comet assay in patients with oral submucous fibrosis. J Investig Clin Dent 2016; 7 (03) 286-293
- 33 Nyamati SB, Annapoorna HB, Tripathi J, Sinha N, Roy S, Agrawal R. Evaluation of serum anti-oxidant enzymes in oral submucous fibrosis and oral squamous cell carcinoma: a clinical and biochemical study. J Adv Med Dent Sci Res 2016; 4: 83-87
- 34 Bale R, Kattappagari KK, Vidya D, Vuddandi S, Gummalla C, Baddam VRR. Oral submucous fibrosis: a quantitative assessment of serum malondialdehyde, superoxide dismutase and correlation with clinical staging. J Oral Maxillofac Pathol 2017; 21 (01) 41-45
- 35 Basu S, Guhan VN. Enzymatic and non-enzymatic anti-oxidants changes in pre-cancerous and cancerous lesions of oral cavity. Med Pulse Int J Biochem 2018; 5: 54-58
- 36 Divyambika CV, Sathasivasubramanian S, Vani G, Vanishree AJ, Malathi N. Correlation of clinical and histopathological grades in oral submucous fibrosis patients with oxidative stress markers in saliva. Indian J Clin Biochem 2018; 33 (03) 348-355
- 37 Param K, Kanchan M, Manish P, Satish K. Assessment of serum paraoxonase-1 enzyme activity, malondialdehyde and vitamin-C in oral premalignancies. Int J Clin Biomed Res 2018; 4: 21-26
- 38 Arya H, Ganvir SM, Begde DN, Passi AD. Comparative evaluation of serum malondialdehyde (MDA) level in oral submucous fibrosis and oral squamous cell carcinoma. J Clin Diagn Res 2019; 13 (06) ZC27-ZC31
- 39 Bathi RJ, Rao R, Mutalik S. GST null genotype and antioxidants: risk indicators for oral pre-cancer and cancer. Indian J Dent Res 2009; 20 (03) 298-303
- 40 Oswal RG, Rao KN, Mall P, Grover I. Evaluation of serum antioxidant enzymes in oral submucous fibrosis and oral squamous cell carcinoma- a clinical and biochemical study. Eur J Mol Clin Med 2020; 7 (08) 3205-3209
- 41 Rai B, Kaur J, Jacobs R, Singh J. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress. J Oral Sci 2010; 52 (02) 251-256
- 42 Shetty SR, Babu S, Kumari S, Shetty P, Hegde S, Castelino R. Status of salivary lipid peroxidation in oral cancer and precancer. Indian J Med Paediatr Oncol 2014; 35 (02) 156-158
- 43 Kaur J, Politis C, Jacobs R. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action. Clin Oral Investig 2016; 20 (02) 315-319
- 44 Akhlaq H, Mehmood N, Azfar M. Increase level of salivary malondialdehyde is associated with decrease mouth opening in stage-I oral submucous fibrosis. Pak J Surg 2017; 33 (03) 195-200
- 45 Banerjee S, Mukherjee S, Mitra S, Singhal P. Comparative evaluation of mitochondrial antioxidants in oral potentially malignant disorders. Kurume Med J 2020; 66 (01) 15-27
- 46 Shahi Y, Samadi FM, Mukherjee S. Plasma lipid peroxidation and anti-oxidant status in patients with oral pre-cancerous lesions and oral cancer. Oral Sci Int 2020; 0: 1-8
- 47 Gupta RK, Patel AK, Shah N. et al Oxidative stress and antioxidants in disease and cancer: a review. Asian Pac J Cancer Prev 2014; 15 (11) 4405-4409